- Daiichi Sankyo Germany seeks to support cancer care in a collaboration with Prosoma by increasing awareness of their digital app ‘Living Well’ which aims to provide a comprehensive programme supporting the mental health of people recently diagnosed with cancer or undergoing treatment
Munich– (23 November, 2022) – Daiichi Sankyo Germany has taken a vital step towards attempting to improve patient care through a recent partnership with Prosoma, a digital therapeutics company specialising in oncology. The partnership intends to promote the use of Prosoma’s digital health app called ‘Living Well’ by reaching out to and generating awareness among the oncology community. ‘Living Well’ is a CE-certified application designed to improve patients’ quality of life and reduce symptoms of stress, anxiety and depression associated with cancer diagnosis and treatment at various stages of cancer.1
“Doing more for patients by expanding our partnerships with providers of support services that can help make a difference in patients’ lives is of the utmost importance for us”, said Dr. Martina Witzel, Head of Oncology Germany. “We believe that there is still an unmet need for mental health support services and that Prosoma is the right partner to help reduce the mental burden for patients.” Piotr Grudzinski, co-founder and CEO of Prosoma GmbH, said: “We’re very appreciative of the support we have received from Daiichi Sankyo Germany. This partnership is incredibly valuable for us and we are happy that this collaboration may help to reach many more patients and aims to alleviate their cancer burden.”
The German insurer Techniker Krankenkasse is the first to reimburse the app as part of their mental health offering, demonstrating that digital health services are getting traction by payors as an important aspect to improve patient outcomes. “Digital health services are becoming ever more significant. We recognize the value of mental health apps such as Prosoma’s “Living Well,” said Thomas Heilmann, Head “Versorgungsmanagement Angebote” at Techniker Krankenkasse.
As a global leader in Digital Therapeutics for oncology, Prosoma provides patients with comprehensive solutions that are fully tailored to their medical conditions. The company created a portfolio of medical software products by combining expertise in medicine and technology and covering cancer patients’ entire behavioural support needs. To learn more about Prosoma, visit www.prosoma.com or connect through LinkedIn.
About ‘Living Well’
Living Well is an application designed to improve the quality of life and reduce stress, anxiety, and depression symptoms related to cancer diagnosis and treatment. It helps patients, and caregivers of cancer patients deal with their emotions and stress, build healthy habits and support them through the recovery process. The application can be used as a tool complementing treatment or as a sole intervention. The Living Well App is already reimbursed by a healthcare insurance company in Germany, and Prosoma is also aiming to have the costs of its products covered by healthcare systems in the US, the UK, and Poland. For more information, please visit www.prosoma.com/en/living-well
1 ‘Living Well’ is a class I medical device in accordance with the Council Directive 93/42/EEC, on medical devices (MDD).